COCRYSTAL PHARMA

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The Company is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). C... C-31244 is currently being evaluated in Phase 2a studies for the treatment of hepatitis C as part of a cocktail for ultra-short therapy. Cocrystal recently entered into an exclusive worldwide license and collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop certain proprietary influenza A/B antiviral agents. CC-42344, the Companyโs molecule for the treatment of influenza A, is currently being evaluated in preclinical IND-enabling studies. In addition, the Company has a pipeline of promising early preclinical programs and continues to identify and develop non-nucleoside polymerase inhibitors for norovirus gastroenteritis using the Companyโs proprietary structure-based drug design technology platform.
COCRYSTAL PHARMA
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2004-01-01
Address:
Bothell, Washington, United States
Country:
United States
Website Url:
http://www.cocrystalpharma.com
Total Employee:
11+
Status:
Active
Contact:
833-475-8247
Email Addresses:
[email protected]
Total Funding:
85.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Similar Organizations
Alzheon
Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
CohBar
CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics.
GenEp
GenEp, Inc. is a pre-clinical stage biotechnology company based on intellectual property assets.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Inhibrx
Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Rebus Biosystems
Rebus Biosystems is a life science technology company creating revolutionary tools to enable spatial omics research without compromise.
Recensa Therapeutics
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.
Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2014-11-25 | RFS Pharma | RFS Pharma acquired by Cocrystal Pharma | N/A |
Official Site Inspections
http://www.cocrystalpharma.com Semrush global rank: 2.08 M Semrush visits lastest month: 10 K
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149

More informations about "Cocrystal Pharma"
Profile :: Cocrystal Pharma, Inc. (COCP)
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company seeking to discover and develop novel antiviral therapeutics as treatments for serious and/or chronic viral diseases.See details»
Overview :: Cocrystal Pharma, Inc. (COCP)
We are a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments.See details»
Overview :: Cocrystal Pharma, Inc. (COCP)
We are a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments.See details»
Cocrystal Pharma - Crunchbase Company Profile
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses.See details»
Cocrystal Pharma, Inc. - LinkedIn
Cocrystal Pharma, Inc. (NASDAQ: COCP) is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of COVID-19 โฆSee details»
Cocrystal Pharma, Inc. (COCP) Company Profile & Overview
Dec 9, 2024 Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases.See details»
Annual Reports :: Cocrystal Pharma, Inc. (COCP)
We are a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments.See details»
Cocrystal Pharma - Craft
Sep 4, 2024 Cocrystal Pharma has 3 employees across 2 locations and $2.01 m in annual revenue in FY 2020. See insights on Cocrystal Pharma including office locations, competitors, โฆSee details»
Cocrystal Pharma Announces First-Patient-In for Phase 2a Human ...
Dec 6, 2023 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โฆSee details»
Cocrystal Pharma Completes $4 Million Private Placement Priced โฆ
BOTHELL, Wash., April 10, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces the completion of a private placement of โฆSee details»
Contact Us :: Cocrystal Pharma, Inc. (COCP)
We are a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments.See details»
Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan โฆ
Apr 24, 2023 We are a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments.See details»
Cocrystal Pharma Reports First Quarter 2024 Financial Results and ...
Mar 31, 2024 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โฆSee details»
Cocrystal Pharma Reports Third Quarter 2023 Financial Results and ...
Nov 13, 2023 Enrollment underway in Phase 1 trial with novel protease inhibitor CDI-988, the first potential dual coronavirus-norovirus oral antiviralDosing expected to begin later this year โฆSee details»
Cocrystal Pharma Reports 2021 Financial Results and Provides โฆ
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โฆSee details»
Cocrystal Pharma Reports First Quarter 2023 Financial Results and ...
May 15, 2023 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โฆSee details»
Cocrystal Pharma Reports First Quarter 2022 Financial Results and ...
May 11, 2022 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โฆSee details»
Cocrystal Pharma Reports 2022 Financial Results and Provides โฆ
Mar 29, 2023 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โฆSee details»
Cocrystal Pharma Reports Second Quarter 2023 Financial Results โฆ
Jun 30, 2023 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โฆSee details»